NVAX logo

Novavax (NVAX) Total expenses

Annual total expenses:

$931.09M-$191.80M(-17.08%)
December 31, 2024

Summary

  • As of today (June 12, 2025), NVAX annual total expenses is $931.09 million, with the most recent change of -$191.80 million (-17.08%) on December 31, 2024.
  • During the last 3 years, NVAX annual total expenses has fallen by -$953.06 million (-50.58%).
  • NVAX annual total expenses is now -58.50% below its all-time high of $2.24 billion, reached on December 31, 2022.

Performance

NVAX Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Quarterly total expenses:

$110.82M-$108.57M(-49.49%)
March 31, 2025

Summary

  • As of today (June 12, 2025), NVAX quarterly total expenses is $110.82 million, with the most recent change of -$108.57 million (-49.49%) on March 31, 2025.
  • Over the past year, NVAX quarterly total expenses has dropped by -$127.86 million (-53.57%).
  • NVAX quarterly total expenses is now -85.33% below its all-time high of $755.49 million, reached on September 30, 2022.

Performance

NVAX Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

NVAX Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.1%-53.6%
3 y3 years-50.6%-72.0%
5 y5 years+528.0%+321.8%

NVAX Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-58.5%at low-85.3%at low
5 y5-year-58.5%+528.0%-85.3%+1091.4%
alltimeall time-58.5%>+9999.0%-85.3%+1075.2%

NVAX Total expenses History

DateAnnualQuarterly
Mar 2025
-
$110.82M(-49.5%)
Dec 2024
$931.09M(-17.1%)
$219.39M(+0.4%)
Sep 2024
-
$218.53M(-14.1%)
Jun 2024
-
$254.49M(+6.6%)
Mar 2024
-
$238.69M(-45.4%)
Dec 2023
$1.12B(-50.0%)
$436.97M(+195.9%)
Sep 2023
-
$147.70M(-60.0%)
Jun 2023
-
$368.97M(+20.4%)
Mar 2023
-
$306.34M(-42.4%)
Dec 2022
$2.24B(+19.1%)
$531.71M(-29.6%)
Sep 2022
-
$755.49M(+12.9%)
Jun 2022
-
$668.88M(+69.2%)
Mar 2022
-
$395.38M(+301.6%)
Dec 2021
$1.88B(+329.1%)
$98.46M(-79.7%)
Sep 2021
-
$485.99M(-24.5%)
Jun 2021
-
$643.85M(-1.8%)
Mar 2021
-
$655.86M(+6950.8%)
Dec 2020
$439.11M(+196.2%)
$9.30M(-97.3%)
Sep 2020
-
$350.97M(+567.7%)
Jun 2020
-
$52.56M(+100.1%)
Mar 2020
-
$26.27M(-30.0%)
Dec 2019
$148.26M(-28.8%)
$37.52M(+41.5%)
Sep 2019
-
$26.51M(-33.8%)
Jun 2019
-
$40.02M(-9.5%)
Mar 2019
-
$44.20M(-16.0%)
Dec 2018
$208.21M(+2.6%)
$52.64M(+6.1%)
Sep 2018
-
$49.63M(-5.9%)
Jun 2018
-
$52.77M(-0.8%)
Mar 2018
-
$53.17M(-8.6%)
Dec 2017
$202.89M(-28.7%)
$58.20M(+16.4%)
Sep 2017
-
$49.98M(+3.7%)
Jun 2017
-
$48.20M(+3.6%)
Mar 2017
-
$46.51M(-21.8%)
Dec 2016
$284.47M(+47.0%)
$59.44M(-10.7%)
Sep 2016
-
$66.54M(-15.8%)
Jun 2016
-
$79.00M(-0.6%)
Mar 2016
-
$79.48M(-6.2%)
Dec 2015
$193.49M(+69.2%)
$84.75M(+113.4%)
Sep 2015
-
$39.72M(+14.1%)
Jun 2015
-
$34.82M(+1.8%)
Mar 2015
-
$34.19M(-10.9%)
Dec 2014
$114.35M(+55.9%)
$38.39M(+37.1%)
Sep 2014
-
$28.00M(+7.3%)
Jun 2014
-
$26.11M(+19.5%)
Mar 2014
-
$21.85M(-5.0%)
Dec 2013
$73.35M(+41.8%)
$23.00M(+14.5%)
Sep 2013
-
$20.08M(+22.2%)
Jun 2013
-
$16.43M(+18.7%)
Mar 2013
-
$13.84M(-1.6%)
Dec 2012
$51.74M(+42.7%)
$14.06M(+11.5%)
Sep 2012
-
$12.61M(-2.7%)
Jun 2012
-
$12.96M(+7.0%)
Mar 2012
-
$12.11M(+19.8%)
Dec 2011
$36.27M(-6.6%)
$10.10M(+12.6%)
Sep 2011
-
$8.98M(+0.6%)
Jun 2011
-
$8.92M(+8.0%)
Mar 2011
-
$8.26M(+16.7%)
Dec 2010
$38.84M
$7.08M(-33.9%)
DateAnnualQuarterly
Sep 2010
-
$10.71M(+13.1%)
Jun 2010
-
$9.47M(-18.1%)
Mar 2010
-
$11.56M(-18.7%)
Dec 2009
$37.71M(+6.4%)
$14.23M(+68.1%)
Sep 2009
-
$8.46M(+7.7%)
Jun 2009
-
$7.86M(+9.8%)
Mar 2009
-
$7.16M(-22.9%)
Dec 2008
$35.42M(+11.5%)
$9.28M(-6.5%)
Sep 2008
-
$9.92M(+16.1%)
Jun 2008
-
$8.55M(+11.3%)
Mar 2008
-
$7.68M(+187.9%)
Dec 2007
$31.78M(+39.1%)
$2.67M(-74.8%)
Sep 2007
-
$10.57M(+19.0%)
Jun 2007
-
$8.88M(+7.0%)
Mar 2007
-
$8.30M(+373.7%)
Dec 2006
$22.85M(+136.6%)
$1.75M(-74.6%)
Sep 2006
-
$6.89M(-12.6%)
Jun 2006
-
$7.88M(+24.3%)
Mar 2006
-
$6.34M(-155.8%)
Dec 2005
$9.66M(-70.5%)
-$11.36M(-376.9%)
Sep 2005
-
$4.10M(-45.6%)
Jun 2005
-
$7.54M(-19.6%)
Mar 2005
-
$9.38M(-21.5%)
Dec 2004
$32.72M(+17.5%)
$11.95M(+302.1%)
Sep 2004
-
$2.97M(-71.3%)
Jun 2004
-
$10.35M(+27.5%)
Mar 2004
-
$8.12M(+14.2%)
Dec 2003
$27.84M(-23.9%)
$7.11M(-1.7%)
Sep 2003
-
$7.23M(+4.7%)
Jun 2003
-
$6.91M(+4.7%)
Mar 2003
-
$6.59M(+0.1%)
Dec 2002
$36.56M(+9.7%)
$6.59M(-25.2%)
Sep 2002
-
$8.81M(-11.8%)
Jun 2002
-
$9.98M(-10.8%)
Mar 2002
-
$11.19M(+22.1%)
Dec 2001
$33.32M(+119.0%)
$9.16M(+23.7%)
Sep 2001
-
$7.41M(-23.0%)
Jun 2001
-
$9.63M(+35.2%)
Mar 2001
-
$7.12M(+20.8%)
Dec 2000
$15.22M(+162.4%)
$5.89M(+57.3%)
Sep 2000
-
$3.75M(+9.7%)
Jun 2000
-
$3.42M(+57.7%)
Mar 2000
-
$2.17M(+20.3%)
Dec 1999
$5.80M(-1.7%)
$1.80M(-5.3%)
Sep 1999
-
$1.90M(+72.7%)
Jun 1999
-
$1.10M(+10.0%)
Mar 1999
-
$1.00M(-47.4%)
Dec 1998
$5.90M(+11.3%)
$1.90M(+26.7%)
Sep 1998
-
$1.50M(+7.1%)
Jun 1998
-
$1.40M(+27.3%)
Mar 1998
-
$1.10M(-21.4%)
Dec 1997
$5.30M(-5.4%)
$1.40M(+7.7%)
Sep 1997
-
$1.30M(-7.1%)
Jun 1997
-
$1.40M(+16.7%)
Mar 1997
-
$1.20M(-33.3%)
Dec 1996
$5.60M
$1.80M(+63.6%)
Sep 1996
-
$1.10M(-21.4%)
Jun 1996
-
$1.40M(+16.7%)
Mar 1996
-
$1.20M

FAQ

  • What is Novavax annual total expenses?
  • What is the all time high annual total expenses for Novavax?
  • What is Novavax annual total expenses year-on-year change?
  • What is Novavax quarterly total expenses?
  • What is the all time high quarterly total expenses for Novavax?
  • What is Novavax quarterly total expenses year-on-year change?

What is Novavax annual total expenses?

The current annual total expenses of NVAX is $931.09M

What is the all time high annual total expenses for Novavax?

Novavax all-time high annual total expenses is $2.24B

What is Novavax annual total expenses year-on-year change?

Over the past year, NVAX annual total expenses has changed by -$191.80M (-17.08%)

What is Novavax quarterly total expenses?

The current quarterly total expenses of NVAX is $110.82M

What is the all time high quarterly total expenses for Novavax?

Novavax all-time high quarterly total expenses is $755.49M

What is Novavax quarterly total expenses year-on-year change?

Over the past year, NVAX quarterly total expenses has changed by -$127.86M (-53.57%)
On this page